Clinical validation of the cobas 4800 HPV test for cervical screening purposes. - Wikidata - awgldk - TriplyDB

Clinical validation of the cobas 4800 HPV test for cervical screening purposes.

Clinical validation of the cobas 4800 HPV test for cervical screening purposes.

http://www.wikidata.org/entity/Q35530540

about

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population.Non-inferiority and superiority tests for partially matched data when a constraint is placed on the number of new tests.A cross-sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women HPV testing by cobas HPV test in a population from Catalonia.Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay.Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium.Feasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: a pilot study in cervical cancer screening.Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix.Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above.HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows Laboratory and clinical aspects of human papillomavirus testing A review of methods for detect human Papillomavirus infection Simultaneous detection, genotyping, and quantification of human papillomaviruses by multicolor real-time PCR and melting curve analysis Comparing the performance of six human papillomavirus tests in a screening population Human Papillomavirus Laboratory Testing: the Changing Paradigm Combination of fluorescence color and melting temperature as a two-dimensional label for homogeneous multiplex PCR detection.HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease.Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening.The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening.Stability of cervical specimens in SurePath medium for human papillomavirus testing with the Roche cobas 4800 assay.Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays.Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening.Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping.Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.Understanding HPV tests and their appropriate applications.Cervical cancer screening: on the way to a shift from cytology to full molecular screening.Molecular approaches for HPV genotyping and HPV-DNA physical status.Hybrid Capture 2 and cobas human papillomavirus assays perform similarly on SurePath samples from women with abnormalities.Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening.Accuracy of self-collected vaginal dry swabs using the Xpert human papillomavirus assay.Reactivation of Latent HPV Infections After Renal Transplantation.The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples.High-risk HPV platforms and test of cure: should specific HPV platforms more suited to screening in a 'test of cure' scenario be recommended?Comparison of the performance of HPV tests in women with abnormal cytology: results of a study within the NHS cervical screening programme.Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer.cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens.Potential Role of E4 Protein in Human Papillomavirus Screening: a Review A comparison of the MeltPro® HPV Test with the Cobas® HPV Test for detecting and genotyping 14 high-risk human papillomavirus types.

P2860

Q26771420-7406B4B9-FFA8-4613-A1BC-B3FDA994D79C Q30301116-AB75666C-FE63-4EF7-8631-452FE01FC846 Q30579744-A4D0C0B6-B8E8-44B5-A3E0-CC5296A6F244 Q33679663-98C1EFD2-8138-4BC6-B798-C9E21F01DCBB Q34618650-1B93D643-F0D3-4B9E-902A-B6AC0313D1D1 Q34637954-FF32F8EE-1301-4B31-B55B-0908EC63F1A9 Q35203306-6078FA8F-ED7B-4FB8-BC2C-39B452C20637 Q35668217-C9726949-19AD-4366-B647-6928732801E3 Q35832553-A70A904C-22ED-4EB3-80B5-3A9CF8FDCB84 Q35867881-85F116F5-9ED6-4519-B709-6FC86641E584 Q35898888-9EBBFD27-3F75-473B-8E51-5A9AE488E2E5 Q36205998-35D420F8-49D9-47D1-804A-679FA176ADC6 Q36311573-E49E33C3-DD92-41C3-8FFE-6906ABAD9A4E Q36427451-8F83599D-B0F9-428C-BC15-A052D6CBE97B Q36559027-89E2DA48-F679-4C9F-BCBA-5CB8C59EBC9A Q36663594-95AD1AA1-9C76-4EAB-9526-2CA078856129 Q36675236-8CFC90CE-2596-499C-B17B-F5206BC63D22 Q36769400-FA7B060C-9D6A-4E07-9107-3C7B36A8A60B Q36856284-82D64C94-3B12-4D99-AB37-49B0F7AEBFDB Q36971059-0B6E13AE-3451-482D-A863-127244B93BA8 Q37218627-FE85F761-7753-4E3E-9A94-52A0E7F8E040 Q37264271-03BB1B45-5CAE-4C30-8961-A50C10649FC0 Q37363392-E8CF8CDD-31A2-4228-838A-08B0029FA781 Q37496183-C202AC64-7A51-4618-995D-02CD35CEA5E8 Q37546224-97351F4C-A2E4-436F-82D1-4C58E22C4142 Q37643509-A2606597-157A-445F-9DE2-72FF3E8FE5BB Q38133612-AD9F6717-CBD2-4F57-8DE0-AE516A76710D Q38180277-F49804CB-2880-426B-8827-E0AA6421ABA8 Q39120200-82961F8C-62DB-452E-B2F8-F998DE09A7D4 Q39909954-B311E461-D8C6-44D7-B14E-A198BD0F593C Q40043990-6DB63F23-6069-4B55-8954-53CF489301CC Q40117003-7D480097-BBF4-4CBC-85D7-0B99EF27A471 Q40397729-A99FE119-FB86-4957-962E-9E43073010B6 Q40749969-20DBDE96-B627-4455-A3F0-66D2242E8A77 Q41654359-09D15649-2D4B-451D-8793-776AA721CC19 Q41719545-0545D3F1-6D4D-463D-A6D5-FE4801ADFDBF Q42245758-792CB7E2-ADED-4D2B-84DD-0CCC92D457C7 Q42251001-D2CD7F24-1799-4F9A-8BDC-80E3031F1845 Q42343538-CE9B267F-26EA-42DD-9530-48A4144C6F27 Q47280015-52DB4AD6-36B6-420B-A479-502B7D5588A1

P2860

Clinical validation of the cobas 4800 HPV test for cervical screening purposes.

http://www.wikidata.org/entity/Q35530540

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Clinical validation of the cobas 4800 HPV test for cervical screening purposes.

@ast

Clinical validation of the cobas 4800 HPV test for cervical screening purposes.

@en

type

label

Clinical validation of the cobas 4800 HPV test for cervical screening purposes.

@ast

Clinical validation of the cobas 4800 HPV test for cervical screening purposes.

@en

prefLabel

Clinical validation of the cobas 4800 HPV test for cervical screening purposes.

@ast

Clinical validation of the cobas 4800 HPV test for cervical screening purposes.

@en

P1433

Q35530540-9B45B79E-E536-43DE-8D5E-F048FDE1776F

P1476

Q35530540-E4A5FEF2-B56C-4F00-AFAB-95D839BFA3E3

P2093

Q35530540-317F327D-2759-4EC8-B34C-A0D163697E0E

Q35530540-77AE4F50-5963-40F0-84FF-9CF63938C69A

Q35530540-79BD71C9-571C-4E12-9357-F6CC9B63EDF7

Q35530540-7EB24C34-0552-4A74-A70A-A4547286A935

Q35530540-8DC004D1-8C7C-4D9B-9FA4-5785D818F4CA

Q35530540-9F7D94D7-16A5-438D-913E-A5D262E3A561

Q35530540-B4580478-A80F-4E3E-9AC7-620118843A51

Q35530540-CA85666A-7C95-4C9E-953C-7EBD29F0D7B6

P2860

Q35530540-0C463776-4BED-4F39-808B-5B4D9A8A099B

Q35530540-3B036077-D8EC-486F-A62B-0D408FFD7037

Q35530540-B30F2432-DF4D-4A5C-A74F-E307AF9F501B

Q35530540-DBF806E7-2793-4E1B-928B-9883153B3216

Q35530540-EA7F032D-0FA9-4E36-BFE4-15AAF7ABF52D

Q35530540-F52D7CA7-9795-4721-8466-954EB366BB2C

P304

Q35530540-BB76F934-5C86-4C12-B0DC-B4E5DF34ECB2

P31

Q35530540-015E1C39-C9CE-4BBE-8279-BB9F3A65FA69

P356

Q35530540-1368BA0A-3B04-4F87-BD71-6C03E3B09BE9

P407

Q35530540-981CB196-DD59-4F40-AA60-AB1FD2AB4592

P433

Q35530540-6DB14658-8EC3-4661-AEDB-31234F9EC394

P478

Q35530540-C76C8AED-2A0C-4C2A-9978-1A9B7C8053D4

P50

Q35530540-1C72B392-6F5C-43F7-99CF-0F2252BB4BFD

P577

Q35530540-C1564BA3-E0FB-4C01-A28A-CDC0F7351DB4

P698

Q35530540-47AC0797-DCEE-4967-9310-A088261AC449

P932

Q35530540-692BC13A-2F26-43DD-8C10-D56BD414D7D6

P356

P1433

Journal of Clinical Microbiology

P1476

Clinical validation of the cobas 4800 HPV test for cervical screening purposes

@en

P2093

A T Hesselink

http://www.w3.org/2001/XMLSchema#string

C J L M Meijer

http://www.w3.org/2001/XMLSchema#string

D A M Heideman

http://www.w3.org/2001/XMLSchema#string

F van Kemenade

http://www.w3.org/2001/XMLSchema#string

J Berkhof

http://www.w3.org/2001/XMLSchema#string

M Verkuijten

http://www.w3.org/2001/XMLSchema#string

N Fransen Daalmeijer

http://www.w3.org/2001/XMLSchema#string

P J F Snijders

http://www.w3.org/2001/XMLSchema#string

P2860

High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study.

GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes.

Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping.

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older.

Validation of high-risk HPV tests for primary cervical screening.

Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (VUSA-screen study).

P304

3983-3985

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.05552-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Willem Melchers

P577

2011-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21880968

http://www.w3.org/2001/XMLSchema#string

P932

3209101

http://www.w3.org/2001/XMLSchema#string